Thursday, 18 December 2014

Perfect presents from Ontario startups

For the frazzled friend

Name of company: InteraXon
Headquarters: Toronto
Name of product: Muse
Price: $299
Muse is a wearable headband that is perfect for anyone who is feeling a little stressed over the holiday season. Developed by Toronto-based startup InteraXon, Muse fits snugly over your forehead and measures your brain signals through a series of sensors. The accompanying mobile app connects to a device via Bluetooth and includes simple games that help to train your brain to stay calm and focused. The app allows users to track their progress and improve their emotional state. Order here

For the fitness fanatic

Name of company: PUSH Inc.
Headquarters: Toronto
Name of product: PUSH Band
Price: $189
Ideal for athletes and fitness enthusiasts, the PUSH Band is a wearable device that straps onto your arm and measures scientifically validated metrics such as reps, sets, force, power, balance, explosive strength and much more. Paired with a mobile app, the PUSH Band allows users to closely monitor and analyze their strength-training exercises and share their progress with their trainer and friends. Users are able to gather deep insights from the device and improve their workout routine. Order here

For anyone, because, robots!

Name of company: GestureSense by XYZ Interactive
Headquarters: Toronto
Name of product: MiP, the gesture-controlled robot by Wow-Wee
Price: $100
MiP is super cute—and up for Toy of the Year! Wow-Wee’s MiP includes GestureSense technology and is for kids ages eight and up. MiP is powered by an iOS or Android smartphone. The loveable nerd in your life can use hand motions to control this balancing robot to play games, tease the family pet and manoeuvre around. Order MiP here.

For the host/hostess with the most-est

Name of company: Milford Bay Trout Farm
Headquarters: Bracebridge, Ontario
Name of product: Smoked Trout, Gravlax or Smoked Trout Pâté
Price: $19 to $35 per pound (smoked trout, gravlax); $6 to $12 (pâté)
Milford Bay Trout Farm is a family business that has been operating in the Muskoka region since 1973. It offers a variety of artisan, hardwood-smoked or cured trout products that would be a welcome treat on any holiday table.
Milford Bay Trout Farm

For the playful programmer

Name of company: Aesthetec Studio
Headquarters: Toronto
Name of product: Little Robot Friends
Price: $50 to $100
Little Robot Friends are cute, programmable robotic characters that serve as a novel entry point for learning code and electronics. Little Robot Friends are compatible with open-source tools, making them a fun and educational way for aspiring makers, both young and old, to experiment with programming and electronics. Little Robot Friends are currently available as a make-your-own version or fully assembled through the company’s Maker Service add-on option. The Little Robot Friends website also contains a number of free tutorials to ease new makers into programming and interacting with their little friends. Order here

For the urban commuter

Name of company: Revelo Electric
Headquarters: Toronto
Name of product: LE-1
Price: $1,300 with end of season sale
For the cycling enthusiast in your life, or maybe for that special someone who wants to begin a more eco-friendly commute in the new year, try Revelo’s LE-1, a made-in-Canada street-legal e-bike with front-wheel pedaling. This extremely light bike, which weighs only 13.8 kilograms (roughly 30 pounds), comes with a powerful 250-watt motor to give boost at takeoff and enable smooth cruising.
This bike also has range. Your loved one can get from Point A to Point B and then some. This bike can travel up to 30 kilometres in one charge. The bonus? It requires only four hours—and costs only five cents of electricity—to fully recharge. Order here

For the one who needs a little extra TLC

Name of company: The Living Kitchen
Headquarters: Toronto
Name of product: Meal Delivery
Price: $100 + delivery (five-meal package); other packages available
The Living Kitchen delivers delicious gluten-free and dairy free meals made from unrefined foods. Designed by a group of holistic nutritionists, chefs and cooks, these healthy meals are ideal for those who are too busy to shop or cook, or who are recovering from serious illnesses. The company specializes in foods to support cancer care. Order here

For the lovable home energy nerd

Name of company: Eyedro Green Solutions
Headquarters: Kitchener, Ont.
Name of product: Eyedro Home Electricity Monitor (EHEM1)
Price: $129
Eyedro has an easy to install, real-time home electricity monitor that will help that special someone in your life easily understand and keep an eye on his or her electricity usage—without waiting for the bill to come in! Combined with the MyEyedro cloud service, two 200A sensors and a three-metre Ethernet cable, Eyedro electricity monitors provide timely and actionable information that will help your loved ones monitor usage, identify problems, reduce waste and ultimately spend less on their electricity, while also making a positive environmental impact. Order here

For those who are esthetically minded

Name of company: Nanoleaf
Headquarters: Toronto
Name of product: Nanoleaf Bloom
Price: $40
Light up that special someone’s life with the Nanoleaf Bloom light bulb! Developed by three University of Toronto alumni, the Nanoleaf Bloom is a revolutionary LED light bulb that works as cool as it looks. Translating regular on/off commands to dimming instructions, it is the first dimmable LED bulb that can dim without a dimmer switch. Nanoleaf Bloom makes it more convenient to save energy, while also allowing you to find that perfect brightness that your heart desires. Cool to the touch and warm to the eyes, the Nanoleaf Bloom produces 1,200 lumens for 10 watts of electricity, equivalent to its 75-watt incandescent counterpart, making it the perfect light for those who value design as much as they do our planet. Order here

Sunday, 23 November 2014

Responsible Leadership: Baroness O'Neill of Bengarve

What would it really take to 'rebuild trust'? 

Baroness Onora O'Neill at TEDx Houses of Parliament 

On trust: claim, aim, and the task

to be competent in a relevant matter



  Tiny, biodegradable sensors could have big potential for all sorts of medical- and food-related industries.


Sick of finding out that your milk is sour only after you’ve taken a big gulp? A new technology will let you simply wave your phone over it—or any food—to get a verdict on whether it’s still edible.


More sophisticated direct quality sensors can monitor compounds in the product/package that are directly related with product quality. 




Saturday, 22 November 2014

Forget Spider-man, and meet Geckoman

This summer, the United States Defense Advanced Research Projects Agency (DARPA) announced that its Z-Man program had, for the first time, made a gecko-adhesive-based climbing system that enabled a person to scale a wall. Although DARPA didn’t provide details on how this was accomplished, the Stanford group, which participated in the Z-Man work, has made a similar demonstration using its own adhesive system. The work is described in research published today in the Journal of the Royal Society Interface.

To make the climbing system, the researchers started with an existing adhesive based on molded microwedges made from a polymer material called PDMS. They attached tiles of this material to a flat, hexagonal, hand-sized gripper. Each gripper was backed with a spring that distributed weight across the pad, and absorbed some of the force involved in climbing. To make climbing easier, the researchers also linked the grippers to platform for a person’s feet, thereby transferring the work of climbing to the legs.
Jeffrey Karp, a bioengineer at Brigham and Women’s Hospital in Boston, notes that the test situation involved a very smooth, clean, flat surface. Karp, who cofounded a company called Gecko Biomedical to commercialize a bioinspired surgical adhesive, says the Stanford researchers will need to show that their system works in less ideal environments. In the real world, a climbing system is liable to be exposed to humidity, rain, pollen, dust, and other contaminants, he notes.
The Stanford group hopes to test the adhesive in especially extreme conditions. This month they tested it in a zero-gravity airplane with NASA and found that it still worked.

Harvard Univ. Gecko Mimicking Adhesives:Karp JM, Mahdavi A, Ferreira L, Carter D, Zumbuehl A, Borenstein J, Bettinger C, Langer R. Gecko Mimicking Adhesives. 2007.


Renewable energy-storage battery hits the market

A startup has started selling a battery that helps solar and wind power operate in remote locations. 

 Ask for more info:

The batteries cost about as much as lead-acid ones, which are sometimes used now, but they last twice as long, effectively cutting the long-term costs in half (see “Demo: Storing the Sun”). Other long-lived batteries exist, but they cost far more than lead-acid batteries.
The new energy storage technology could be crucial to making renewable energy more viable, especially in remote locations. By making solar power cheaper than diesel fuel in many places, it could help bring clean power to some of the more than one billion people in the world without reliable electricity (see “A Billion People in the Dark”).

Friday, 14 November 2014

One Start Competition deadline 1 Dec 2014


Initiative for Women in Business Experts Speaker Series

Collective Genius: The Art and Practice of Leading Innovation

Why can some organizations innovate time and again, while most cannot? You might think the key to innovation is attracting exceptional creative talent, making the right investments or breaking down organizational silos. All of these things may help, but there’s only one way to ensure sustained innovation: you need to lead it—and with a special kind of leadership. “Collective Genius” shows you how.
Join the Initiative for Women in Business at the Rotman School of Management, University of Toronto on Wednesday, November 19, 2014 from 5 – 7 p.m. to discuss Collective Genius: The Art and Practice of Leading Innovation with author and guest speaker Linda A. Hill, Professor of Business Administration at Harvard Business School and faculty chair of the Leadership Initiative.



Friday, 1 August 2014


Two projects involving Oxford University technology are winners of 2014 Google Impact Challenge, and will each receive £500,000.

Life-changing ideas win Google Impact Challenge

Smart glasses for people with sight loss to make the most of their remaining vision – a partnership between the Royal National Institute of Blind People and a research team in the Nuffield Department of Clinical Neurosciences led by Dr Stephen Hicks, which won as the 'People's Choice' following a public vote.
Wearable acoustic sensors to track disease-carrying mosquitoes in Indonesia – a programme led by Royal Botanic Gardens Kew and Oxford's Department of Engineering Science, Malaria Atlas Project and the Eijkman Oxford Clinical Research Unit in Jakarta, which was selected by a panel of judges as one of this year's three other winners.

Saturday, 26 April 2014

Ontario Tax Exemption for Commercialization

digital technology
How to apply for a tax refund available to eligible start-ups that are commercializing intellectual property developed at Canadian universities and colleges.
Read More

Reza Moridi

Minister of Research and Innovation

The Ministry of Research and Innovation supports world-class research, commercialization and innovation taking place across Ontario through a range of programs and services like the Ontario Research Fund, Innovation Demonstration Fund and Ontario Venture Capital Fund.

The real impact of venture capital on Canadian businesses

Data released by CVCA - Canada's Venture Capital & Private Equity Association shows a 31% increase in venture capital investments in 2013, with total venture capital financing reaching a six-year high of $2 billion.
This SlideShare showcases results for the Canadian venture capital industry during 2013 as well as the real impact venture capital has had on Canadian businesses.

Monday, 14 April 2014

John R. Evans Leaders Fund - National Announcement

John R. Evans Leaders Fund - National Announcement - Canada News Centre

...As Canada's population ages, the number of Canadians
living with dementia is projected to double within a generation, thereby
affecting 1.1 million people and costing Canada's health care system in
excess of $150 billion.

It is therefore the kind of research our government is proud to sponsor.

Today, I am happy to announce that our government is investing in the state-of-the-art equipment necessary to build Dr. Heisz's Neurophysiology of Fitness Lab.

I am also pleased to announce that our government is investing more than $30.4 million in state-of-the-art equipment and infrastructure at 32 universities across Canada.

 Read More....

Speaking Points

The Honourable Ed Holder, PC, MP
Minister of State (Science and Technology)

Hamilton, Ontario

April 14, 2014

Sunday, 16 February 2014

Monitoring the state of food

Professor Lord John Krebs Kt FRS
Professor of Zoology & Principal of Jesus College Oxford
Baron John Krebs is the head of the UK's Food Standards Agency (FSA), between 2005 and 2008 he was the Royal Society Research Professor at Oxford.

In 2007 he chaired a working party of the Nuffield Council on Bioethics to produce a report on the Ethics of Public Health. He sits in the House of Lords as an independent cross-bencher and is Chairman of the House of Lords Science and Technology Select Committee.
He is also a Trustee of the Nuffield Foundation, Chairman of the UK Science and Technology Honours Committee.   He sits on the UK Climate Change Committee and chair its Adaptation Sub-Committee.  In 2012-3 I was President of the British Science Association.

His research interests lie in quantitative and experimental behavioural ecology and population biology, especially of bird populations.
He is a cross-bencher in the House of Lords and the Chairman of the House of Lords Science and Technology Select Committee. In 2007, he chaired a working party of the Nuffield Council on Bioethics to produce a report on the Ethics of Public Health. He is a Trustee of the Nuffield Foundation and Chairman of the UK Science and Technology Honours Committee. He sits on the UK Climate Change Committee and chairs its Adaptation Sub-Committee.
John Krebs was the first chairman of the UK Food Standards Agency from 2000 to 2005 and has a strong interest in all aspects of food policy.
His book, "Food, a very short introduction" (working title) will be published by Oxford University Press in 2013.

Monday, 27 January 2014

Google buys UK artificial intelligence start-up DeepMind

Google has bought UK start-up DeepMind for a reported $400m (£242m), making the artificial intelligence firm its largest European acquisition so far.
DeepMind was founded by 37-year-old neuroscientist and former teenage chess prodigy Demis Hassabis, along with Shane Legg and Mustafa Suleyman.
The artificial intelligence company specialises in algorithms and machine learning for e-commerce and games.
Technology news website Re/code first reported the purchase price.
But Google declined to confirm the figure, while privately-held DeepMind was not immediately available for comment.

Read More......

Saturday, 7 December 2013

Seedrs Appoints World-Class Advisory Board

Earlier this month, we announced our newly-appointed Advisory Board made up of four world-class individuals. We’re thrilled to welcome to the Seedrs family: 
  • James Alexander, co-founder of Zopa and partner at The Foundation. 
  • Mike Butcher, European Editor of TechCrunch.
  • Lord Lucas, Member of the House of Lords and Chief Editor of The Good Schools Guide. 
  • Dale Murray, British Angel Investor of the Year 2011, Non-Executive Director of UK Government’s Department of Business, Innovation & Skills (BIS) and of UK Trade and Investment (UKTI). 
  • Read their bios here..........

Monday, 25 November 2013

MinION™ device: a miniaturised sensing system

Nanopore sensing technology can be miniaturised into a portable device for electronic single molecule sensing. This is possible because of recent advances made by Oxford Nanopore in using new polymers to form robust, long lasting bilayers on its proprietary arrayed sensing chip.
The MinION™  system is a disposable device that contains the sensor chip, ASIC and nanopores that are needed to perform a complete single molecule sensing experiment. Plugging directly into a laptop or desktop computer through a USB port, it is a self-contained device to deliver real-time experimental data.
The MinION device is adaptable for DNA sequencing, protein sensing and other nanopore sensing techniques.
Workflows are similar to those of the GridION system. The system can run with Oxford Nanopore bioinformatic solutions or the user's own analysis systems in real-time, as the experiment is being performed.
Oxford Nanopore is focused on delivering the simplest possible sample preparation and workflows. The system is designed to be compatible with complex samples such as blood or serum and environmental samples such as water samples

Read More.....

Saturday, 16 November 2013

Oxbridge to Invest Up to $1 Billion in Medical Commercial Developments in US, Canada & Internationally

Oxbridge to Invest Up to $1 Billion in Medically Anchored Mixed Use Commercial Developments in the United States, Canada and Internationally

LONDON, UNITED KINGDOM and VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 19, 2013) - Oxbridge Capital today announced that it would invest up to $ 1 billion over the next 60 months in developing healthcare anchored mixed use commercial real estate developments in the United States, Canada and internationally. See
According to investment guidance made public today, Oxbridge will develop these substantial real estate capital plays alongside a number of key strategic partners, including:
  • Integrated healthcare service providers, including companies providing a full range of physiotherapy, surgical, pharmaceutical, senior care and other services;

  • Hospital groups and integrated healthcare delivery systems;

  • REITs, including those involved in all aspects of mixed use commercial development, acquisition, finance and management;

  • Private equity real estate investment funds;

  • Investment management, infrastructure and other specialized funds;

  • Insurance companies;

  • Design build consortia, including large and well known construction and facilities maintenance operators in Canada, the United States, Europe and Asia; and

  • Various real estate development and structured finance professions in Toronto, New York, London and Singapore.

In structuring these investments, Oxbridge will leverage up to $250 million in internally generated and/or externally sourced funds and leverage the same with a combination of conventional bank debt, bond issuances, high yield financing, tax exempt offerings, structured finance and additional equity and debt offerings in the public and private markets. Oxbridge expects to announce its first set of transactions, including related financings approaching $500mm, within the next 12 to 18 weeks. The Company is already in advanced discussions on a number of potential projects in the United States, Canada and elsewhere.
Owners and operators of healthcare facilities and or development sites seeking to access these investment funds are encouraged to submit a brief business profile to
About Oxbridge Capital Group
Oxbridge Capital is a private equity group that acts as financial sponsor for transactions in a number of key sectors, including real estate, transportation and logistics, hospitality, healthcare and energy and power. The principals at Oxbridge, its financing partners and related entities, have played an instrumental role in negotiating, structuring, and/or placing more than $20 billion in debt and equity securities over the past 20 years. See

Gene Therapy Start up

Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases.
Our founding team has led the advancement of gene therapy research for nearly two decades, building a recognized center of gene therapy innovation in research, translation and manufacturing at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics (CCMT).
Spark Therapeutics is the next phase of our founders’ commitment. We are building a fully-integrated gene therapy company to realize the vision of delivering multiple products to address debilitating diseases. With a $50 million commitment from The Children’s Hospital of Philadelphia and exclusive technology agreements with multiple academic institutions, we have the capabilities needed to advance our clinical programs and deliver innovative medicines for those in need. Many of the CCMT’s leaders will assume management roles within Spark or engage with the company as scientific advisors, including Katherine A. High, M.D., a gene therapy pioneer who has served as the director of the CCMT since its inception.
Our team’s experience in the clinical study of gene therapy—from designing and manufacturing vectors to conducting studies that have shown strong potential for safety and efficacy—is unparalleled in the field. Clinical-grade vectors prepared by our team have been used to safely treat more than 100 human subjects in 12 clinical trials in the U.S. and EU, across five parenteral routes of administration in genetic and non-genetic diseases. No other group can claim this breadth of expertise and experience in human gene therapy.
The adeno-associated virus (AAV) vectors used in our clinical programs have been demonstrated to be safe and effective vehicles for delivering genetic material into targeted cells, providing unique advantages over alternative therapeutic approaches. We have established human proof of concept in two organ systems—the eye and the liver—and are advancing a Phase 3 program in blindness caused by mutations of the RPE65 gene; a Phase 1/2 program in hemophilia B; and preclinical programs in neurodegenerative diseases and other hematologic disorders and forms of inherited blindness.

Sunday, 3 November 2013

IRISS EyE Check Device for Non-Specialists

Eye Health Informatics

iPad Displaying Eye Check StatisticsThe IRISS device captures in real-time crucial data relating to the eyes: pupil sizes, cornea diameter, palpebral aperture and so on. This data is aggregated on a Cloud-based platform where normative values are established. This in turn shows the clinician, in real time, a range of values for every eye-feature and assists them in making clinical decisions with regard to potential underlying conditions such as anisocoria, ptosis, buphthalmos and others.

The American Association of Paediatrics, the American Association of Paediatric Ophthalmology and Strabismus as well as the UK National Screening Committee and similar bodies around the world recommend that children undergo vision screening at least by the age of 4-5. The problem lies in the fact that while it is very desirable to detect these conditions even in babies and infants, this pre-verbal (often uncooperative) population, is very difficult to screen and diagnose accurately and reliably. This is the reason why many cases of amblyopia and strabismus are detected at the age of 6 or more, when it is almost too late for effective treatment. Hence there is a need for reliable and practical automatic screening and diagnostic technologies for these conditions.

Request Quotation:

The IRISS Eye Check provides a quick, easy and cost-effective method of screening for the condition that will both reduce over- and under-referrals and complement current examination techniques.

Tuesday, 22 October 2013

Society of Vacuum Coaters

Motion Control and Automation Technology NASA

Motion Control and Automation Technology
Anti-Icing Formulas Prevent Train Delays
In the winter of 2009, Washington, DC workers faced the prospect of a difficult commute due to record-setting snowfall. But thousands of the city's Metrorail riders found the public transportation system fully functional, thanks in part to a NASA technology invented years before. Just like trains...
Spacesuit Simulator Meets NASA Training Needs
Aurora Flight Sciences delivered a completed Space Suit Simulator (S3) to NASA following the successful completion of a Phase II Small Business Innovation Research (SBIR) effort. The S3 was developed to meet NASA's research and training needs. Pressurized spacesuits impose high joint torques on the astronaut, reducing mobility for upper and lower body motions. Because of the highly altered mobility...
A Short-Range Distance Sensor with Exceptional Linearity
A sensor has been demonstrated that can measure distance over a total range of about 300 microns to an accuracy of about 0.1 nm (resolution of about 0.01 nm). This represents an exceptionally large dynamic range of...
Miniature Trace Gas Detector Based on Microfabricated Optical Resonators
While a variety of techniques exist to monitor trace gases, methods relying on absorption of laser light are the most commonly used in terrestrial applications. Cavity-enhanced absorption techniques typically use...
Non-Magnetic, Tough, Corrosion- and Wear-Resistant Knives From Bulk Metallic Glasses and Composites
Quality knives are typically fabricated from high-strength steel alloys. Depending on the application, there are different requirements for mechanical and physical properties that cause problems for steel alloys..

Sunday, 13 October 2013

SME Smart IP Scheme (SSIPS)

ISIS Innovation
Two new initiatives were launched to make it even more attractive for clients to engage with Isis. An easy-to-use Materials Evaluation Agreement was launched by Isis, Imperial Innovations and UCL Business, to help companies evaluate new materials from the research laboratories of these three universities. Isis also launched its SME Smart IP Scheme (SSIPS) which offers greater flexibility and reduced business risk for SMEs accessing Intellectual Property (IP) from Oxford University. SSIPS ensures that, whatever the ultimate route to market, the SME that invested in the development will earn a share of future revenues. Furthermore, Isis works with SSIPS partners to access support initiatives such as TSB Smart Awards and R&D tax credits. 


Wednesday, 2 October 2013

Oral Drug Delivery Carrier

Oral Drug Delivery Carrier - Isis Project No 710155

Technology Source: Keele University

An oral, enteric drug delivery vehicle targeting PepT1 for increased bioavailability.
At the heart of this invention is a new approach to oral drug delivery. This is via a drug carrier system targeting the protein PepT1, allowing the oral administration of drugs that would otherwise need to be given by injection.

Unmet need

The market for improving oral bioavailability of drugs was estimated at $20B in 2010, highlighting it as a major issue for large and small biopharmaceutical companies that are looking to add high value to existing compounds. About 50% of new drugs with the desired biological activity fail to reach the market because of poor oral bioavailability, transport problems, or metabolism by the liver. For many drugs, the absorption is so low as to be ineffective, leading to further problems such as:
  • The bulk of the expensive drug (e.g. 90%) is wasted, so 10 times as much drug must be administered to achieve the desired medicinal effect
  • Drugs with low absorption usually show highly variable absorption between patients – e.g. 10% average absorption might have a 3-fold range either side of this value, with some patients absorbing 3% (limited benefit) and others 30% (potential side-effects)
This delivery system might thus provide a reliable protocol for achieving high oral bioavailability, which would overcome all of the problems outlined above.

The technology

Work on the bioavailability mechanisms led the researchers to explore the binding/transport of a thiodipeptide, which was found to be much more stable than normal peptides, but which was rapidly transported by PepT1. This was modified to create a 'carrier' molecule to which drugs could be attached. Although the primary focus is on the design of a drug carrier system, the expertise of the inventors also enables them to design small modifications to drugs that might allow them to be absorbed via PepT1 without compromising their biological efficacy. A number of drug conjugates have been tested in vivo, using single dose oral administration to rats, and monitoring blood plasma levels of the conjugate. The results show that the conjugates are orally absorbed in vivo, and this approach should have wide-ranging applicability.

Status and next steps

The team, comprising Prof. Patrick Bailey and others at Keele University, are keen to out-license this invention to a party that has capabilities to apply it across targeted therapy areas. The invention has been patented in several
major jurisdictions internationally.

Research group

Patrick Bailey is Professor of Chemistry and Dean of Faculty of Natural Sciences at Keele University. His research has focused on protein mechanisms, most recently on peptide transporters, and on synthesis of alkaloids with valuable pharmaceutical properties.

Request further information....

Thursday, 26 September 2013

Social Mobility: the greatest challenge of our time?

Education Endowment Foundation 

Sir Peter Lampl is Chair of the Education Endowment Foundation and the Sutton Trust.

The Sutton Trust-EEF Teaching and Learning Toolkit is an accessible summary of educational research which provides guidance for teachers and schools on how to use their resources to improve the attainment of disadvantaged pupils.

The Toolkit currently covers 33 topics, each summarised in terms of their average impact on attainment, the strength of the evidence supporting them and their cost.
The Toolkit is a live resource which will be updated on a regular basis as findings from EEF-funded projects and other high-quality research become available. In addition, we would welcome suggestions for topics to be included in future editions. If you have a topic suggestion, or any other comments or questions about the Toolkit, please contact Robbie Coleman at

Saturday, 21 September 2013

Oxford Entrepreneurs

 Please submit your interest below if you had like to participate to be contacted.
Please submit your interest below if you’d like to participate and someone will follow up shortly:
Please submit your interest below if you’d like to participate and someone will follow up shortly:
Please submit your interest below if you’d like to participate and someone will follow up shortly:
Please submit your interest below if you’d like to participate and someone will follow up shortly:
Mentor – Email:

Cutting Edge Technology: Meet Lisa at Oxford

Begbroke Science Park RoboticsMeet Lisa. This is the latest big thing in the world of autonomously driven vehicles. Being currently developed by Prof. Paul Newman (Department of Engineering) and his research team at Begbroke Science Park, Lisa can be used in a variety of civilian and defence applications.
To read more click here.  

Laser Therapy for tissue generation

Toronto-based Theralase Inc. has collaborated with Ontario Centres of Excellence (OCE) and the University Health Network (UHN) for over a decade to develop its industry leading line of Low Level Laser Therapy products used in hospitals and medical clinics across North America.
Designed to treat wounds, increase tissue regeneration and reduce inflammation and pain, Theralase is the creator of one of only three FDA NHN (non-heating) approved therapeutic medical lasers licensed in the US and the only therapeutic laser system approved for chronic knee pain.
Read More...............

Friday, 13 September 2013



Social Media Groups

If you are using social media, you can apply to join the OBA Network Facebook and LinkedIn groups. Connect with business alumni and friends online, add to your social networks and find out about the latest alumni and School news. You can also join the relevant LinkedIn group just for your class, if you are an Oxford Alumnus, which will be listed on the drop down menu.
Please select a social media group below.